Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Abstract Cancer, characterized by its immune evasion, active metabolism, and heightened proliferation, comprises both stroma and cells. Although the research has always focused on parenchymal cells, the non-parenchymal components must not be overlooked. Targeting cancer parenchymal cells has proven...
Saved in:
| Main Authors: | Keke Lv, Tianlin He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-12-01
|
| Series: | Molecular Biomedicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43556-024-00233-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The malignant dialogue between cancer-associated fibroblasts and osteosarcoma cells: microenvironment-mediated drug resistance and therapeutic targets
by: Xiufeng Wang, et al.
Published: (2025-08-01) -
Cancer‐Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets
by: Yutao Li, et al.
Published: (2025-07-01) -
WISP1 drives esophageal squamous cell carcinoma progression via modulation of cancer-associated fibroblasts and immune microenvironment
by: Zhiqiang Yi, et al.
Published: (2025-07-01) -
Research advances in the effect of cancer-associated fibroblasts on the biological behavior and treatment of malignant tumors
by: YUN Jie, BIAN Chao, LI Zhijun
Published: (2025-06-01) -
Cancer-associated fibroblast-mediated immune evasion: molecular mechanisms of stromal-immune crosstalk in the tumor microenvironment
by: Junling Luo, et al.
Published: (2025-08-01)